{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T14:40:06Z","timestamp":1735742406947,"version":"3.32.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.pnpbp.2005.04.005","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T13:39:48Z","timestamp":1117633188000},"page":"770-774","source":"Crossref","is-referenced-by-count":6,"title":["High vulnerability to acute dystonic reactions: A case of antipsychotic exposure and uncontrolled seizure activity"],"prefix":"10.1016","volume":"29","author":[{"given":"Gara L.","family":"Coffey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila R.","family":"Botts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4 Suppl.","key":"10.1016\/j.pnpbp.2005.04.005_bib1","first-page":"1","article-title":"Practice guidelines for the treatment of patients with schizophrenia","volume":"154","author":"American Psychiatric Association","year":"1997","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2005.04.005_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)91581-4","article-title":"Association of dopamine D2 receptor molecular variant with schizophrenia","volume":"343","author":"Arinami","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2005.04.005_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","article-title":"A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia","volume":"6","author":"Arinami","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2005.04.005_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v66n0103","article-title":"The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation","volume":"66","author":"de Leon","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.005_bib5","first-page":"2725","article-title":"The paroxysmal dyskinesias","volume":"vol. 3","author":"Fahn","year":"1997"},{"key":"10.1016\/j.pnpbp.2005.04.005_bib6","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.pnpbp.2005.04.005_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2850.2000.00296.x","article-title":"What can we do about acute extrapyramidal symptoms?","volume":"7","author":"Gray","year":"2001","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"10.1016\/j.pnpbp.2005.04.005_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-199819010-00005","article-title":"Managing antipsychotic-induced acute and tardive dystonia","volume":"19","author":"Raja","year":"1998","journal-title":"Drug Safety"},{"key":"10.1016\/j.pnpbp.2005.04.005_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1684\/j.1950-6945.1999.tb00303.x","article-title":"Epilepsy and paroxysmal movement disorders in families: evidence for shared mechanisms","volume":"1","author":"Singh","year":"1999","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.pnpbp.2005.04.005_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3 receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2005.04.005_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1020464017021","article-title":"Safety and tolerability: how do newer generation \u201catypical\u201d antipsychotics compare?","volume":"73","author":"Tandon","year":"2002","journal-title":"Psychiatr. Q."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584605001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T13:59:11Z","timestamp":1735739951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584605001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0278584605001247"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2005.04.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}